Somatostatin analogs in patients with Zollinger Ellison syndrome (ZES): an observational study.

Sara MassironiFederica CavalcoliAlessandra ElveviMaurizio QuatriniPietro Invernizzi

Published in: Endocrine (2021)

Present data support the use of SSAs in ZES, considering that gastrinoma is mainly a well-differentiated low-grade tumor (G1 or G2), with a high expression of somatostatin receptors.

Keyphrases

low grade
high grade
neuroendocrine tumors
poor prognosis
electronic health record
molecular docking
big data
case report
long non coding rna
machine learning
deep learning